Literature DB >> 27326324

Glycine Transporter 1 Inhibitors and the Promise of a New Schizophrenia Therapy.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2016        PMID： 27326324      PMCID： PMC4904256          DOI： 10.1021/acsmedchemlett.6b00183

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?

Authors:  Philipp Singer; Sylvain Dubroqua; Benjamin K Yee
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  Glycine reuptake inhibition as a new therapeutic approach in schizophrenia: focus on the glycine transporter 1 (GlyT1).

Authors:  Pierre Chue
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 3.  Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.

Authors:  Robert J Harvey; Benjamin K Yee
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.